Serum anti-PLA2R antibodies may be present before clinical manifestations of membranous nephropathy

Kidney Int. 2016 Jun;89(6):1399. doi: 10.1016/j.kint.2015.11.032.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Autoantibodies / blood*
  • Biopsy
  • Creatinine / blood
  • Cyclophosphamide / therapeutic use
  • Drug Therapy, Combination / methods
  • Enzyme-Linked Immunosorbent Assay
  • Fluorescent Antibody Technique
  • Glomerulonephritis, Membranous / blood*
  • Glomerulonephritis, Membranous / drug therapy
  • Glomerulonephritis, Membranous / immunology
  • Glomerulonephritis, Membranous / pathology
  • Glomerulosclerosis, Focal Segmental / blood*
  • Glomerulosclerosis, Focal Segmental / drug therapy
  • Glomerulosclerosis, Focal Segmental / immunology
  • Glomerulosclerosis, Focal Segmental / pathology
  • Glucocorticoids / therapeutic use
  • Humans
  • Immunologic Factors / therapeutic use
  • Immunosuppressive Agents / therapeutic use
  • Kidney / pathology
  • Male
  • Receptors, Phospholipase A2 / immunology*
  • Rituximab / therapeutic use

Substances

  • Autoantibodies
  • Glucocorticoids
  • Immunologic Factors
  • Immunosuppressive Agents
  • Receptors, Phospholipase A2
  • Rituximab
  • Cyclophosphamide
  • Creatinine